<TABLE> <S> <C>
<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE AUDITED
FINANCIAL STATEMENTS INCLUDED IN THE REGISTRANT'S FROM 10-KSB FOR THE YEAR ENDED
SEPTEMBER 30, 2000 AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH
FINANCIAL STATEMENTS.
</LEGEND>
<CIK> 0000822418
<NAME> Bio-Imaging Technologies, Inc.
<MULTIPLIER> 1
<CURRENCY> U.S. Dollars
<S> <C>
<PERIOD-TYPE> YEAR
<FISCAL-YEAR-END> SEP-30-2000
<PERIOD-START> OCT-01-1999
<PERIOD-END> SEP-30-2000
<EXCHANGE-RATE> 1
<CASH> 491,048
<SECURITIES> 0
<RECEIVABLES> 1,692,457
<ALLOWANCES> 65,000
<INVENTORY> 0
<CURRENT-ASSETS> 2,352,706
<PP&E> 3,209,906
<DEPRECIATION> 1,917,562
<TOTAL-ASSETS> 3,906,812
<CURRENT-LIABILITIES> 2,408,944
<BONDS> 164,139
0
104
<COMMON> 1,944
<OTHER-SE> 1,331,681
<TOTAL-LIABILITY-AND-EQUITY> 3,906,812
<SALES> 0
<TOTAL-REVENUES> 5,772,443
<CGS> 0
<TOTAL-COSTS> 3,619,343
<OTHER-EXPENSES> 2,753,510
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 92,021
<INCOME-PRETAX> (692,431)
<INCOME-TAX> 0
<INCOME-CONTINUING> (692,431)
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> (692,431)
<EPS-BASIC> (0.09)<F1>
<EPS-DILUTED> (0.09)<F2>
<FN>
<F1> This amount represents Basic Earnings per Share in accordance with the
requirements of Statement of Financial Accounting Standards No. 128 -
"Earnings per Share".
<F2> This amount represents Diluted Earnings per Share in accordance with the
requirements of Statement of Financial Accounting Standards No. 128 -
"Earnings per Share".
</FN>
</TABLE>